课题基金 / 基金详情

PTHrP on normal osteoblast differentiation and function

PTHrP on normal osteoblast differentiation and function
PTHrP 对正常成骨细胞分化和功能的影响
批准号:
7456364
负责人:
RAMIRO Eliseo TORIBIO
金额:
$12.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2010-06-30

项目摘要

项目成果

RAMIRO Eliseo TORIBIO的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): Ramiro Toribio,DVM,博士打算成为一名独立的科学家,研究内分泌激素及其在骨骼生物学和病理学中的作用,以支持学术界和生物医学研究的职业生涯。Ramiro Toribio博士于2001年获得钙调节博士学位,并获得美国兽医内科学院的董事会认证(1999年),并于2001年加入托马斯罗索尔博士的实验室担任博士后。Toribio博士目前是俄亥俄州州立大学兽医生物科学系的助理教授。他的研究目标是研究甲状旁腺相关蛋白(PTHrP)对骨髓基质细胞(BMSC)向成骨细胞谱系的承诺和成骨细胞功能的作用。这个概念与医学有关,并将具有临床应用,因为骨量减少(骨质疏松症)和骨脆性增加是影响数百万美国人的疾病。该奖项将解决有关PTHrP和骨骼生物学的重要生物医学问题,并将为Toribio博士提供成为独立调查员所需的技能。 研究:PTHrP最初被确定为恶性肿瘤体液性高钙血症(HHM)的一个因素。目前认为PTHrP是一种内分泌、旁分泌和自分泌因子,具有多种生理功能。 已显示PTHrP通过与PTH-1受体(PTH 1 R)结合而在骨和肾中发挥甲状旁腺素样作用。PTHrP基因的缺失是致命的,并导致骨骼发育异常。最近的研究还表明,PTHrP对细胞功能的一些影响是由核定位信号介导的。由于有关PTHrP对成骨细胞功能的作用的信息有限,并且我们的实验室一直致力于研究PTHrP和骨生物学的重要方面,因此要测试的总体假设是PTHrP在BMSC向成骨细胞谱系的承诺中很重要。成骨细胞功能。为了实现这一目标,将进行一系列研究。目的1利用PTHrP和PTH 1 R基因敲除小鼠骨髓间充质干细胞和成骨细胞,以及成骨细胞和脂肪细胞系,研究PTHrP对成骨细胞分化和功能的影响。目的二是利用新的动物模型研究PTHrP对骨髓基质细胞和成骨细胞功能的影响。PTHrP基因的缺失和细胞特异性的过度表达将为PTHrP在骨发育中的作用提供相关信息。目的3探讨PTHrP核定位信号对骨髓基质细胞和成骨细胞功能的影响。我们已经取得了相当大的进展,为我们未来的研究开发基因工程小鼠(见初步数据)。这些实验的结果将有助于更好地了解PTHrP在骨生理学和病理生理学中的作用,以及创造治疗骨病的新药物。 工作环境:兽医生物科学系是一个成功的单位,拥有内分泌学,免疫学,病毒学,分子生物学和生物化学领域的研究人员。托马斯罗索尔的实验室将提供一个良好的环境,发展必要的技能,成为一个成功的独立研究人员。
英文摘要
DESCRIPTION (provided by applicant): Ramiro Toribio, DVM, PhD intends to become an independent scientist studying endocrine hormones and their role in skeletal biology and pathology in order to support a career in academia and biomedical research. Dr. Ramiro Toribio completed a PhD in calcium regulation in 2001, is board-certified by the American College of Veterinary Internal Medicine (1999), and in 2001 joined the laboratory of Dr. Thomas Rosol in a postdoctoral position. Dr. Toribio is currently an Assistant Professor in the Department of Veterinary Biosciences, the Ohio State University. His research goals are to investigate the role of parathyroid hormone-related protein (PTHrP) on the commitment of bone marrow stromal cells (BMSCs) to the osteoblastic lineage and on osteoblast function. This concept is relevant to medicine and will have clinical applications because decreased bone mass (osteoporosis) and increased bone fragility are conditions that affect millions of Americans. This award will address important biomedical questions with regard to PTHrP and skeletal biology and it will provide Dr. Toribio with the skills necessary to become an independent investigator. Research: PTHrP was initially identified as a factor responsible for humoral hypercalcemia of malignancy (HHM). It is now recognized that PTHrP is an endocrine, paracrine, and autocrine factor with multiple physiological functions. PTHrP has been shown to exert parathyroid hormone-like actions in bone and kidney by binding to the PTH-1 receptor (PTH1R). Deletion of the PTHrP gene is lethal and results in abnormal skeletal development. Recent studies have also shown that some of the effects of PTHrP on cell function are mediated by a nuclear localization signal. Since there is limited information on the role of PTHrP on osteoblast function and our laboratory has been dedicated to study important aspects of PTHrP and bone biology, the overall hypothesis to be tested is that PTHrP is important in the commitment of BMSCs to the osteoblastic lineage and for osteoblast function. To accomplish this goal a series of studies will be performed. Aim 1 will Investigate the role of PTHrP on osteoblast differentiation and function by using BMSCs and osteoblasts from PTHrP and PTH1R knock-out mice as well as by using osteogenic and adipocytic cell lines. Aim 2 will use novel animal models to study the function of PTHrP on BMSC and osteoblast function. PTHrP gene deletion and overexpression in a cell-specific manner will provide relevant information on the role of PTHrP in bone development. Aim 3 will investigate the role of the nuclear localization signal of PTHrP on BMSC and osteoblast function. We have made considerable progress to develop genetically-engineered mice for our future studies (see preliminary data). Results from these experiments will contribute to a better understanding on the role of PTHrP in bone physiology and pathophysiology, and in the creation of new agents to treat bone disease. Environment: The Department of Veterinary Biosciences is a successful unit with extramurally funded researchers in the areas of endocrinology, immunology, virology, molecular biology, and biochemistry. Dr. Thomas Rosol's laboratory will provide an excellent environment for developing the skills necessary to become a successful independent researcher.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Deletion of the nuclear localization sequence and C-terminus of parathyroid hormone-related protein decreases osteogenesis and chondrogenesis but increases adipogenesis and myogenesis in murine bone marrow stromal cells.
甲状旁腺激素相关蛋白的核定位序列和C末端的缺失减少了成骨和软骨发生,但增加了鼠骨髓基质细胞中的脂肪形成和肌发生。
DOI: 10.1177/2041731415609298
发表时间: 2015-01
期刊: Journal of tissue engineering
影响因子: 8.2
作者: [Hildreth BE 3rd, Hernon KM, Dirksen WP, Leong J, Supsavhad W, Boyaka PN, Rosol TJ, Toribio RE]
通讯作者: Toribio RE
SMALL LAB ANIMAL IMAGING: PROSTATE CANCER, BREAST CANCER
  • 批准号:
    7334989
  • 项目类别:
  • 资助金额:
    $6.87万
  • 财政年份:
    2006
  • 负责人:
    RAMIRO Eliseo TORIBIO
  • 依托单位:
SMALL LAB ANIMAL IMAGING: BONE DISEASES, OSTEOPOROSIS
  • 批准号:
    7334990
  • 项目类别:
  • 资助金额:
    $18.31万
  • 财政年份:
    2006
  • 负责人:
    RAMIRO Eliseo TORIBIO
  • 依托单位:
SMALL LAB ANIMAL IMAGING: LEUKEMIA, LUNG CANCER
  • 批准号:
    7334992
  • 项目类别:
  • 资助金额:
    $6.87万
  • 财政年份:
    2006
  • 负责人:
    RAMIRO Eliseo TORIBIO
  • 依托单位:
Small Laboratory Animal Imaging: High Resolution Microcomputed Tomography System
  • 批准号:
    7047441
  • 项目类别:
  • 资助金额:
    $45.78万
  • 财政年份:
    2006
  • 负责人:
    RAMIRO Eliseo TORIBIO
  • 依托单位:
海外基金